CHF Solutions, Inc. is a medical device company that focuses on commercializing the Aquadex SmartFlow System, which provides aquapheresis therapy for patients with fluid overload who have failed diuretic therapy. The system is indicated for both temporary and extended ultrafiltration treatment and must be administered by healthcare providers trained in extracorporeal therapies. The company aims to predict, measure, and control patient fluid balance through technology and collaboration. CHF Solutions is headquartered in Minneapolis, Minnesota, with subsidiaries in Australia and Ireland, and has been listed on the NASDAQ Capital Market since 2012.